Fairmount Funds Management as of June 30, 2024
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 13 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 21.5 | $190M | 2.4M | 80.50 | |
| Nuvalent Inc-a (NUVL) | 16.5 | $146M | 1.9M | 75.86 | |
| Spyre Therapeutics Com New (SYRE) | 10.7 | $95M | 4.0M | 23.51 | |
| Apogee Therapeutics (APGE) | 9.1 | $81M | 2.0M | 39.35 | |
| Enliven Therapeutics (ELVN) | 8.5 | $75M | 3.2M | 23.37 | |
| Dianthus Therapeutics (DNTH) | 8.1 | $72M | 2.8M | 25.88 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 6.8 | $60M | 3.2M | 18.67 | |
| Cogent Biosciences (COGT) | 5.9 | $53M | 6.2M | 8.43 | |
| Astria Therapeutics (ATXS) | 3.7 | $32M | 3.6M | 9.10 | |
| Protagonist Therapeutics (PTGX) | 3.6 | $32M | 932k | 34.65 | |
| Miragen Therapeutics (VRDN) | 2.7 | $24M | 1.8M | 13.01 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.4 | $22M | 1.1M | 20.24 | |
| Terns Pharmaceuticals (TERN) | 0.6 | $5.1M | 749k | 6.81 |
